Terms: = Endocrine gland cancer AND DNMT3A, Q9Y6K1, 1788, ENSG00000119772, DNMT3A2, M_HsaIIIA AND Treatment
26 results:
1. Clinical and genetic analysis of a case of Gitelman syndrome accompanied with Graves disease and adrenocortical adenoma: A case report.
Qiao Y; Zhao J; Wu J; Cao L; Song G; Mao J
Medicine (Baltimore); 2024 Apr; 103(15):e37770. PubMed ID: 38608089
[TBL] [Abstract] [Full Text] [Related]
2. The frequency of mutations in advanced thyroid cancer in Japan: a single-center study.
Toda S; Iwasaki H; Okubo Y; Hayashi H; Kadoya M; Takahashi H; Yokose T; Hiroshima Y; Masudo K
Endocr J; 2024 Jan; 71(1):31-37. PubMed ID: 38044137
[TBL] [Abstract] [Full Text] [Related]
3. DNA hypermethylation driven by DNMT1 and dnmt3a favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma.
Kerdivel G; Amrouche F; Calmejane MA; Carallis F; Hamroune J; Hantel C; Bertherat J; Assié G; Boeva V
Clin Epigenetics; 2023 Aug; 15(1):121. PubMed ID: 37528470
[TBL] [Abstract] [Full Text] [Related]
4. Facility type is associated with improved perioperative and oncologic outcomes after minimally invasive surgery for pancreatic cancer.
Servin-Rojas M; Shafique N; Sell NM; Gamblin TC; Qadan M
HPB (Oxford); 2023 Aug; 25(8):933-940. PubMed ID: 37149486
[TBL] [Abstract] [Full Text] [Related]
5. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
6. [Ginsenoside 20(S)-Rg3 upregulates tumor suppressor VHL gene expression by suppressing dnmt3a-mediated promoter methylation in ovarian cancer cells].
Wang L; Han X; Zheng X; Zhou Y; Hou H; Chen W; Li X; Zhao L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):100-106. PubMed ID: 33509760
[TBL] [Abstract] [Full Text] [Related]
7. MiR-146b-5p Regulates the Expression of Long Noncoding RNA
Peng Y; Fang X; Yao H; Zhang Y; Shi J
Cancer Biother Radiopharm; 2021 Jun; 36(5):433-440. PubMed ID: 32343601
[No Abstract] [Full Text] [Related]
8. Acromegaly in the setting of Tatton-Brown-Rahman Syndrome.
Hage C; Sabini E; Alsharhan H; Fahrner JA; Beckers A; Daly A; Salvatori R
Pituitary; 2020 Apr; 23(2):167-170. PubMed ID: 31858400
[TBL] [Abstract] [Full Text] [Related]
9. Regulation of carcinogenesis and modulation through Wnt/β-catenin signaling by curcumin in an ovarian cancer cell line.
Yen HY; Tsao CW; Lin YW; Kuo CC; Tsao CH; Liu CY
Sci Rep; 2019 Nov; 9(1):17267. PubMed ID: 31754130
[TBL] [Abstract] [Full Text] [Related]
10. miR-145 promotes miR-133b expression through c-myc and dnmt3a-mediated methylation in ovarian cancer cells.
Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of dnmt3a alterations in Middle Eastern papillary thyroid carcinoma.
Siraj AK; Pratheeshkumar P; Parvathareddy SK; Bu R; Masoodi T; Iqbal K; Al-Rasheed M; Al-Dayel F; Al-Sobhi SS; Alzahrani AS; Al-Dawish M; Al-Kuraya KS
Eur J Cancer; 2019 Aug; 117():133-144. PubMed ID: 31280122
[TBL] [Abstract] [Full Text] [Related]
12. miR-603 targeted hexokinase-2 to inhibit the malignancy of ovarian cancer cells.
Lu J; Wang L; Chen W; Wang Y; Zhen S; Chen H; Cheng J; Zhou Y; Li X; Zhao L
Arch Biochem Biophys; 2019 Jan; 661():1-9. PubMed ID: 30365936
[TBL] [Abstract] [Full Text] [Related]
13. Intermediate-Risk Papillary Thyroid cancer: Risk Factors for Early Recurrence in Patients with Excellent Response to Initial Therapy.
Llamas-Olier AE; Cuéllar DI; Buitrago G
Thyroid; 2018 Oct; 28(10):1311-1317. PubMed ID: 30105948
[TBL] [Abstract] [Full Text] [Related]
14. Double-negative feedback interaction between DNA methyltransferase 3A and microRNA-145 in the Warburg effect of ovarian cancer cells.
Zhang S; Pei M; Li Z; Li H; Liu Y; Li J
Cancer Sci; 2018 Sep; 109(9):2734-2745. PubMed ID: 29993160
[TBL] [Abstract] [Full Text] [Related]
15. A Double-Negative Feedback Interaction between MicroRNA-29b and dnmt3a/3B Contributes to Ovarian cancer Progression.
Teng Y; Zuo X; Hou M; Zhang Y; Li C; Luo W; Li X
Cell Physiol Biochem; 2016; 39(6):2341-2352. PubMed ID: 27832631
[TBL] [Abstract] [Full Text] [Related]
16. Downregulation of dnmt3a expression increases miR-182-induced apoptosis of ovarian cancer through caspase-3 and caspase-9-mediated apoptosis and DNA damage response.
Lu W; Lu T; Wei X
Oncol Rep; 2016 Dec; 36(6):3597-3604. PubMed ID: 27748882
[TBL] [Abstract] [Full Text] [Related]
17. Emodin enhances the demethylation by 5-Aza-CdR of pancreatic cancer cell tumor-suppressor genes P16, RASSF1A and ppENK.
Pan FP; Zhou HK; Bu HQ; Chen ZQ; Zhang H; Xu LP; Tang J; Yu QJ; Chu YQ; Pan J; Fei Y; Lin SZ; Liu DL; Chen L
Oncol Rep; 2016 Apr; 35(4):1941-9. PubMed ID: 26782786
[TBL] [Abstract] [Full Text] [Related]
18. Minimally invasive video-assisted thyroidectomy: reflections after more than 2400 cases performed.
Miccoli P; Biricotti M; Matteucci V; Ambrosini CE; Wu J; Materazzi G
Surg Endosc; 2016 Jun; 30(6):2489-95. PubMed ID: 26335076
[TBL] [Abstract] [Full Text] [Related]
19. Aberrant DNA methyltransferase expression in pancreatic ductal adenocarcinoma development and progression.
Gao J; Wang L; Xu J; Zheng J; Man X; Wu H; Jin J; Wang K; Xiao H; Li S; Li Z
J Exp Clin Cancer Res; 2013 Nov; 32(1):86. PubMed ID: 24423239
[TBL] [Abstract] [Full Text] [Related]
20. microRNA-199a-3p, dnmt3a, and aberrant DNA methylation in testicular cancer.
Chen BF; Gu S; Suen YK; Li L; Chan WY
Epigenetics; 2014 Jan; 9(1):119-28. PubMed ID: 23959088
[TBL] [Abstract] [Full Text] [Related]
[Next]
